Forcyte Biotechnologies
PrivateLast Round
Seed
Jun 1, 2022
Total Funding Raised
$2.54M
Company Overview
Forcyte Biotechnologies operates in Healthcare & Life Sciences and is based in Los Angeles, California. Its latest recorded funding round was a Seed round in June 2022.
Forcyte Biotechnologies is a biotechnology company that provides a proprietary, high-throughput screening platform called FLECS to quantify cellular contractile forces for drug discovery.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Biotech Equipment
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Forcyte Biotechnologies Comparables
Compare Forcyte Biotechnologies with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Cell4D | 78% | |
| Functional Fluidics | 77% | |
| Medera | 77% |
For institutional investors. Book with your work email.
Forcyte Biotechnologies Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Jun 1, 2022 | ||||
| Accelerator | Mar 23, 2021 | ||||
| Grant | Sep 11, 2019 | ||||
| Seed | Jan 15, 2019 | ||||
| Grant | Jul 24, 2018 |
For institutional investors. Book with your work email.
Forcyte Biotechnologies Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Pioneer Fund | Seed |
| NIH RADx | Grant |
| Acequia Capital | Seed |
| Y Combinator | Accelerator, Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 1, 2022
Raised a seed round with participation from Acequia Capital and Pioneer Fund.
- Mar 23, 2021
$125K raised from Y Combinator
For institutional investors. Book with your work email.
Forcyte Biotechnologies Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Forcyte Biotechnologies's valuation, stock price, and market status.
Is Forcyte Biotechnologies a public or private company?
Forcyte Biotechnologies is a private company.
What is the current stock price of Forcyte Biotechnologies?
Forcyte Biotechnologies is a private company, so its shares have no public market price. Caplight tracks Forcyte Biotechnologies's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Forcyte Biotechnologies worth (valuation)?
Valuation information for Forcyte Biotechnologies is not publicly available.
Can I buy Forcyte Biotechnologies stock?
Forcyte Biotechnologies shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Forcyte Biotechnologies's last funding round?
Forcyte Biotechnologies's most recent funding round was Seed on June 1, 2022.
Who are the main investors in Forcyte Biotechnologies?
Key investors in Forcyte Biotechnologies include Pioneer Fund, NIH RADx, Acequia Capital, Y Combinator.
Will Forcyte Biotechnologies IPO soon?
No public IPO plans have been announced for Forcyte Biotechnologies.
How can I track Forcyte Biotechnologies secondary market activity?
Caplight tracks bids, offers, and trades in Forcyte Biotechnologies's shares on secondary markets.